(1)

Regulation (EU) 2015/2283 provides that only novel foods authorised and included in the Union list of novel foods may be placed on the market within the Union.

(2)

Pursuant to Article 8 of Regulation (EU) 2015/2283, Commission Implementing Regulation (EU) 2017/2470 (2) has established a Union list of novel foods.

(3)

The Union list set out in the Annex to Implementing Regulation (EU) 2017/2470 includes infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner as an authorised traditional food from a third country.

(4)

Commission Implementing Regulation (EU) 2020/917 (3) authorised the placing on the market of infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner as a traditional food from a third country for use in herbal infusions.

(5)

On 4 July 2022, the company Luigi Lavazza Spa (‘the applicant’) submitted an application to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 for a change of the conditions of use of the infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner. The applicant requested to extend its use to flavoured and unflavoured non-alcoholic ready-to-drink beverages and coffee, coffee and chicory extracts, instant coffee, tea, herbal- and fruit-infusions, coffee substitutes, coffee mixes and instant mixes for beverages (and their flavoured counterparts) intended for the general population.

(6)

The Commission considers that the requested update of the Union list is not liable to have an effect on human health and that a safety evaluation by the European Food Safety Authority (‘the Authority’) in accordance with Article 10(3) of Regulation (EU) 2015/2283 is not necessary. The proposed uses of the infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner will result in intakes that are comparable to intakes from the currently authorised uses which were assessed by the Authority and considered by the Authority as safe and which supported the authorisation of the traditional food from a third country. Therefore, it is appropriate to amend the conditions of use of the infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner to extend its use to flavoured and unflavoured non-alcoholic ready-to-drink beverages and coffee, coffee and chicory extracts, instant coffee, tea, herbal- and fruit-infusions, coffee substitutes, coffee mixes and instant mixes for beverages (and their flavoured counterparts).

(7)

The information provided in the application gives sufficient grounds to establish that the changes to the conditions of use of the traditional food from a third country are in accordance with the conditions laid down in Article 12 of Regulation (EU) 2015/2283 and should be approved.

(8)

Taking into account this extension of use of the infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner to additional food categories and for the purpose of clarity and understanding of food categories, initially authorised food category ‘Herbal infusions’ is changed to ‘Infusion from coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner to be placed on the market as such’, while ‘herbal infusions’ are included in the food category ‘coffee, coffee and chicory extracts, instant coffee, tea, herbal- and fruit-infusions, coffee substitutes, coffee mixes and instant mixes for beverages (and their flavoured counterparts)’.

(9)

The Annex to Implementing Regulation (EU) 2017/2470 should therefore be amended accordingly.

(10)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

(1)

Part B of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances approved under Regulation (EC) No 1107/2009.

(2)

The approval period of the active substance pyridalyl was extended from 30 June 2024 until 30 June 2025 by Commission Implementing Regulation (EU) 2020/2007 (3), in order to ensure a balanced distribution of responsibilities and work among Member States acting as rapporteur and co-rapporteur Member States, taking into account also the resources necessary for the renewal assessment and decision-making.

(3)

No application for the renewal of the approval of this active substance was submitted in accordance with Article 5 of Commission Implementing Regulation (EU) 2020/1740 (4).

(4)

The extension of the approval period of the active substance pyridalyl provided for by Implementing Regulation (EU) 2020/2007 is no longer justified. It is therefore appropriate to provide that the approval of this substance expires at the date it would have expired without the extension.

(5)

Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

(6)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

(1)

The accounts of the European Central Bank (ECB) and of the national central banks of the Member States whose currency is the euro are to be audited by independent external auditors recommended by the Governing Council of the ECB and approved by the Council of the European Union.

(2)

The mandate of Mazars Réviseurs d’entreprises/Mazars Bedrijfsrevisoren SCRL/CVBA as current external auditors of the Nationale Bank van België/Banque Nationale de Belgique expired following the audit for the 2022 financial year. It is therefore necessary to appoint external auditors for the 2023 financial year.

(3)

The Nationale Bank van België/Banque Nationale de Belgique has selected KPMG Bedrijfsrevisoren/KPMG Réviseurs d’Entreprises BV/SRL as its external auditors for the financial years 2023 to 2028.

(4)

The Governing Council of the ECB recommended that KPMG Bedrijfsrevisoren/KPMG Réviseurs d’Entreprises BV/SRL be appointed as the external auditors of the Nationale Bank van België/Banque Nationale de Belgique for the financial years 2023 to 2028.

(5)

Following the recommendation of the Governing Council of the ECB, Council Decision 1999/70/EC (2) should be amended accordingly,